Clover Health Investments (CLOV) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
CLOV dips 2.3% to $4.68. Closed at $4.68, -2.30% vs the prior close of $4.79. Day range $4.61–$4.76, opened at $4.71.
CLOV daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — CLOV dips 2.3% to $4.68
- Closed at $4.68, -2.30% vs the prior close of $4.79. Day range $4.61–$4.76, opened at $4.71.
- Volume was 3.37M shares, 0.8x its 50-day average of 4.41M.
- Price is +4.8% vs its 50-day average ($4.47) and +36.6% vs its 200-day average ($3.43).
- 52-week range $1.58–$5.59; today's close sits at 77% of that range, 16.3% below the 52-week high.
Oct 14, 2026 — CLOV dips 0.4% to $4.79
- Closed at $4.79, -0.42% vs the prior close of $4.81. Day range $4.73–$4.89, opened at $4.76.
- Volume was 3.76M shares, 0.9x its 50-day average of 4.40M.
- Price is +7.5% vs its 50-day average ($4.46) and +40.2% vs its 200-day average ($3.42).
- 52-week range $1.58–$5.59; today's close sits at 80% of that range, 14.3% below the 52-week high.
Oct 13, 2026 — CLOV rises 0.6% to $4.81
- Closed at $4.81, +0.63% vs the prior close of $4.78. Day range $4.65–$4.90, opened at $4.78.
- Volume was 3.79M shares, 0.9x its 50-day average of 4.41M.
- Price is +8.2% vs its 50-day average ($4.44) and +41.3% vs its 200-day average ($3.40).
- 52-week range $1.58–$5.59; today's close sits at 81% of that range, 14.0% below the 52-week high.
Oct 12, 2026 — CLOV ends flat (-0.2%) to $4.78
- Closed at $4.78, -0.21% vs the prior close of $4.79. Day range $4.69–$4.86, opened at $4.78.
- Volume was 3.89M shares, 0.9x its 50-day average of 4.40M.
- Price is +7.8% vs its 50-day average ($4.44) and +40.9% vs its 200-day average ($3.39).
- 52-week range $1.58–$5.59; today's close sits at 80% of that range, 14.5% below the 52-week high.
Oct 9, 2026 — CLOV jumps 4.6% to $4.79 on 2.5x normal volume
- Closed at $4.79, +4.59% vs the prior close of $4.58. Day range $4.64–$5.21, opened at $5.17.
- Volume was 10.55M shares, 2.5x its 50-day average of 4.24M — unusually heavy trading.
- Price is +8.3% vs its 50-day average ($4.42) and +41.6% vs its 200-day average ($3.38).
- 52-week range $1.58–$5.59; today's close sits at 80% of that range, 14.3% below the 52-week high.
- SEC filings that day: 8-K.
Oct 8, 2026 — CLOV rises 0.4% to $4.58
- Closed at $4.58, +0.44% vs the prior close of $4.56. Day range $4.44–$4.60, opened at $4.50.
- Volume was 5.52M shares, 1.3x its 50-day average of 4.23M.
- Price is +3.8% vs its 50-day average ($4.41) and +35.9% vs its 200-day average ($3.37).
- 52-week range $1.58–$5.59; today's close sits at 75% of that range, 18.1% below the 52-week high.
Oct 7, 2026 — CLOV dips 0.9% to $4.56
- Closed at $4.56, -0.87% vs the prior close of $4.60. Day range $4.53–$4.75, opened at $4.55.
- Volume was 7.42M shares, 1.8x its 50-day average of 4.16M.
- Price is +3.5% vs its 50-day average ($4.41) and +35.7% vs its 200-day average ($3.36).
- 52-week range $1.58–$5.59; today's close sits at 74% of that range, 18.4% below the 52-week high.
Oct 6, 2026 — CLOV dips 1.7% to $4.60
- Closed at $4.60, -1.71% vs the prior close of $4.68. Day range $4.58–$4.69, opened at $4.68.
- Volume was 3.35M shares, 0.8x its 50-day average of 4.16M.
- Price is +4.5% vs its 50-day average ($4.40) and +37.3% vs its 200-day average ($3.35).
- 52-week range $1.58–$5.59; today's close sits at 75% of that range, 17.7% below the 52-week high.
Oct 5, 2026 — CLOV jumps 6.8% to $4.68
- Closed at $4.68, +6.85% vs the prior close of $4.38. Day range $4.35–$4.71, opened at $4.39.
- Volume was 4.88M shares, 1.2x its 50-day average of 4.12M.
- Price is +6.5% vs its 50-day average ($4.40) and +40.1% vs its 200-day average ($3.34).
- 52-week range $1.58–$5.59; today's close sits at 77% of that range, 16.3% below the 52-week high.
Oct 2, 2026 — CLOV jumps 3.5% to $4.38
- Closed at $4.38, +3.55% vs the prior close of $4.23. Day range $4.22–$4.41, opened at $4.27.
- Volume was 3.86M shares, 0.9x its 50-day average of 4.12M.
- Price is -0.2% vs its 50-day average ($4.39) and +31.5% vs its 200-day average ($3.33).
- 52-week range $1.58–$5.59; today's close sits at 70% of that range, 21.6% below the 52-week high.
CLOV latest news & SEC filings
Every SEC filing by or about CLOV in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 15, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Oct 15, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Oct 15, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Oct 15, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Oct 15, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Oct 9, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Oct 7, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Reynoso Jamie L. sold 2,006 shares at $4.63 (≈$9.29K) on Oct 7, 2026; now holds 2,792,690
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 25, 2026 · 8-K/A — Amended current report
Amended current report
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Sep 24, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Aug 20, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 7, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $743.17M (prior year $477.62M) (+55.6% vs Jun 30, 2025)
- Net income: $28.00M (prior year -$10.58M) (swung to profit vs Jun 30, 2025)
- Diluted EPS: $0.05 (prior year -$0.02) (swung to profit vs Jun 30, 2025)
Aug 5, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 17, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Jun 18, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Things to know before you trade CLOV
- Last results release: Aug 5, 2026 (8-K Item 2.02). Previous ones: May 6, 2026, Feb 26, 2026, Aug 5, 2025. Based on that rhythm, the next report is likely around Nov 4, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.89% (largest 6.8%).
- Liquidity: about 4.35M shares (≈$20.34M) trade per day on average.
- 52-week position: $4.68 vs a range of $1.58–$5.59 (77% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Jamie L. Reynoso sold 1,921 shares on Sep 17, 2026.
- Latest filings: 8-K Oct 9, 2026; 8-K Sep 24, 2026; 8-K Aug 20, 2026.
- Listing: Nasdaq · industry: Hospital & Medical Service Plans.
CLOV market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 4.71 | 4.76 | 4.61 | 4.68 | 3.37M |
| Oct 14, 2026 | 4.76 | 4.89 | 4.73 | 4.79 | 3.76M |
| Oct 13, 2026 | 4.78 | 4.90 | 4.65 | 4.81 | 3.79M |
| Oct 12, 2026 | 4.78 | 4.86 | 4.69 | 4.78 | 3.89M |
| Oct 9, 2026 | 5.17 | 5.21 | 4.64 | 4.79 | 10.55M |
| Oct 8, 2026 | 4.50 | 4.60 | 4.44 | 4.58 | 5.52M |
| Oct 7, 2026 | 4.55 | 4.75 | 4.53 | 4.56 | 7.42M |
| Oct 6, 2026 | 4.68 | 4.69 | 4.58 | 4.60 | 3.35M |
| Oct 5, 2026 | 4.39 | 4.71 | 4.35 | 4.68 | 4.88M |
| Oct 2, 2026 | 4.27 | 4.41 | 4.22 | 4.38 | 3.86M |
| Oct 1, 2026 | 4.25 | 4.31 | 4.11 | 4.23 | 3.58M |
| Sep 30, 2026 | 4.27 | 4.41 | 4.22 | 4.31 | 3.34M |
| Sep 29, 2026 | 4.33 | 4.35 | 4.26 | 4.32 | 2.65M |
| Sep 28, 2026 | 4.45 | 4.53 | 4.27 | 4.33 | 3.33M |
| Sep 25, 2026 | 4.53 | 4.67 | 4.47 | 4.49 | 3.60M |
| Sep 24, 2026 | 4.59 | 4.65 | 4.43 | 4.51 | 3.20M |
| Sep 23, 2026 | 4.66 | 4.66 | 4.47 | 4.57 | 3.33M |
| Sep 22, 2026 | 4.61 | 4.69 | 4.52 | 4.67 | 4.52M |
| Sep 21, 2026 | 4.53 | 4.57 | 4.45 | 4.54 | 2.84M |
| Sep 18, 2026 | 4.50 | 4.51 | 4.36 | 4.46 | 6.17M |
About Clover Health Investments
Clover Health Investments (CLOV) is listed on the Nasdaq and classified by the SEC under “Hospital & Medical Service Plans”. Its business address is in JERSEY CITY, NJ. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1801170.
CLOV board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Carladenise Armbrister Edwards | Director | May 19, 2026 |
| Vivek Garipalli | Director | Jan 9, 2026 |
| Demetrios L. Kouzoukas | Director | Jan 8, 2026 |
| Anna U Loengard | Director | Jan 8, 2026 |
| William G Jr Robinson | Director | Jan 8, 2026 |
| Andrew Toy | Chief Executive Officer | Aug 10, 2026 |
| Thomas L Tran | Director | Jan 8, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Peter J. Kuipers | Chief Financial Officer | Feb 2, 2026 |
| Joseph Frank Oldakowski | VP OF FINANCE AND CONTROLLER | Sep 17, 2026 |
| Brady Patrick Priest | CEO of Clover Care Services | May 13, 2026 |
| Jamie L. Reynoso | CEO, Medicare Advantage | Sep 18, 2026 |
| Karen Soares | Chief Legal Officer | Sep 15, 2026 |
| Joseph Clay Thornton | Interim CFO | Aug 17, 2026 |
| Andrew Toy | Chief Executive Officer | Aug 10, 2026 |
| Conrad Wai | CEO, Counterpart Health | Sep 16, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 17, 2026 | Jamie L. Reynoso | Sale | 1,921 | $4.56 |
| Sep 16, 2026 | Joseph Frank Oldakowski | Sale | 3,170 | $4.64 |
| Sep 15, 2026 | Conrad Wai | Sale | 300,000 | $4.72 |
| Sep 15, 2026 | Jamie L. Reynoso | Sale | 9,273 | $4.78 |
| Sep 15, 2026 | Karen Soares | Sale | 6,846 | $4.78 |
| Sep 14, 2026 | Joseph Frank Oldakowski | Sale | 20,000 | $5.16 |
| Aug 17, 2026 | Joseph Clay Thornton | Sale | 17,775 | $4.39 |
| Aug 10, 2026 | Andrew Toy | Sale | 87,798 | $4.65 |
| Jul 20, 2026 | Karen Soares | Sale | 51,700 | $4.51 |
| Jul 17, 2026 | Jamie L. Reynoso | Sale | 4,839 | $4.53 |
| Jul 15, 2026 | Joseph Clay Thornton | Sale | 4,630 | $4.67 |
| Jul 15, 2026 | Karen Soares | Sale | 10,519 | $4.67 |
| Jul 15, 2026 | Conrad Wai | Sale | 24,215 | $4.67 |
| Jul 15, 2026 | Jamie L. Reynoso | Sale | 13,119 | $4.67 |
| Jul 15, 2026 | Andrew Toy | Sale | 62,711 | $4.67 |
CLOV financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $1.92B | $-85.55M | — | $-66.93M |
| Dec 31, 2024 | $1.37B | $-43.01M | — | $34.84M |
| Dec 31, 2023 | $1.26B | $-213.36M | -0.44 | $-144.66M |
| Dec 31, 2022 | $1.10B | $-339.57M | -0.71 | $-203.93M |
| Dec 31, 2021 | $1.47B | $-587.76M | -1.42 | $-282.33M |
Latest balance sheet: total assets $720.33M, total liabilities $344.07M, cash $78.30M (as of Jun 30, 2026).
CLOV earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 5, 2026 | 8-K Item 2.02 (results) | $4.14 |
| May 6, 2026 | 8-K Item 2.02 (results) | $2.68 |
| Feb 26, 2026 | 8-K Item 2.02 (results) | $2.15 |
| Aug 5, 2025 | 8-K Item 2.02 (results) | $2.85 |
| May 6, 2025 | 8-K Item 2.02 (results) | $3.35 |
| Feb 27, 2025 | 8-K Item 2.02 (results) | $4.14 |
| Nov 6, 2024 | 8-K Item 2.02 (results) | $4.35 |
| Aug 5, 2024 | 8-K Item 2.02 (results) | — |
| May 7, 2024 | 8-K Item 2.02 (results) | — |
| Mar 12, 2024 | 8-K Item 2.02 (results) | — |
| Nov 6, 2023 | 8-K Item 2.02 (results) | — |
| Aug 8, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Hospital & Medical Service Plans
UnitedHealth (UNH)Elevance Health (ELV)Cigna (CI)Humana (HUM)Centene (CNC)Oscar Health (OSCR)Molina Healthcare (MOH)Alignment Healthcare (ALHC)Trupanion (TRUP)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on CLOV
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.